SRDX - Surmodics Corp Net earnings per share (EPS TTM)

Symbol and logo of brand Surmodics Corp (SRDX)

The TTM EPS history of Surmodics, Inc. (SRDX) demonstrates the efficiency of catheter coating logistics, where supply diversification supports high profitability. -1.24 serves as the current parameter value, underscoring the company's status as a trusted B2B developer of safe surface modifications. Financial stability is based on a balance of licensing royalties and proprietary sales within the vascular surgery segment.

SRDX (surmodics.com) Net earnings per share for the last 12 months history from 07/04/2022 to 11/29/2025
Mass-produced product of Surmodics Inc

To select high-quality assets, an investor must compare market value with the actual efficiency of capital management. This metric is calculated as the ratio of total annual net income to the number of shares, which allows for an assessment of Surmodics, Inc. (SRDX) patent monetization under strict FDA regulation, filtering out market noise via a 12-month net income per share chart.

Direct competitors

DXCM: Net earnings per share for the last 12 months|penumbrainc.com - Earnings per share for the last four quarters|NOVT: Net earnings per share (EPS TTM)|HAE - Net earnings per share for the last four quarters|INSP (Inspire Sleep) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Procept (PRCT)|Net earnings per share for the last 12 months CNMD (CONMED Corporation)|PLSE (pulsebiosciences.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months InMode INMD|PMI - Net earnings per share for the last 12 months|Eversense - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months NeuroPace Medical|TCMD: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SNWV|OM (Outset Medical) - Net earnings per share (EPS TTM)|Electromed Inc (ELMD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) LNSR|Net earnings per share for the last 12 months AVITA Medical Inc RCEL|Net earnings per share (EPS TTM) PROF (Profound Medical)|Net earnings per share (EPS TTM) Baird Medical Investment Holdings BDMD|EDAP - Earnings per share for the last twelve months|APYX: Earnings per share for the last twelve months|ICCM (icecure-medical.com) - Net earnings per share for the last 12 months|Pulmonx - Earnings per share for the trailing year|TELA (TELA Bio Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months CytoSorbents Corp. CTSO|Earnings per share for the last twelve months Sensus Healthcare (SRTS)|Zynex Medical (ZYXI) - Net earnings per share for the trailing year|electroCore - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Vicarious Surgical Inc RBOT|Inspira Technologies Oxy B.H.N. Ltd - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters seastarmedical.com ICU|iridex.com (IRIX) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months INBS (Intelligent Bio Solutions Inc.)|Earnings per share for the last twelve months Beyond Air Inc|Net earnings per share for the last 12 months Profusa, Inc (PFSA)|Net earnings per share (EPS TTM) SSKN|GCTK - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months NanoVibronix NAOV|VERO: Earnings per share for the last 12 months|NUWE: Net earnings per share for the last 12 months|Aethlon Medical Corp - Earnings per share for the last four quarters|asensus.com (ASXC) - Earnings per share for the last twelve months|AVGR - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months BSGM|Net earnings per share (EPS TTM) Cutera Inc.|Earnings per share for the last twelve months Know Labs Corp (KNW)|NARI (Inari Medical Corp) - Earnings per share for the trailing year|Earnings per share for the last twelve months Nevro Corp. NVRO|RSLS - Net earnings per share for the last 12 months|SILK - Earnings per share for the last twelve months